I’ve worked with psychedelics for more than a decade now, but only recently have I begun recommending microdoses—here in Colorado, where cultivation and use are protected under state and local law.

Like many others, I wondered whether microdosing offered much beyond a placebo effect, or figured larger psychedelic experiences were simply more meaningful and more useful.

What I’ve come to notice, however, is that even if microdosing does not live up to every claim made on its behalf, it can still offer people who are new to psychedelics a gentler way in. For some, it becomes a first step that makes a larger therapeutic dose feel less intimidating and more approachable later on.

If you’re considering microdosing and hoping to find a single source that proves it is either a miracle or complete hype, you’re likely to come away disappointed. The truth is more nuanced than that. In this article, I try to bring that nuance into focus by placing personal experience and scientific research at the same table. But first, it helps to be clear about what microdosing actually is.

What Is Microdosing?

Broadly speaking, microdosing refers to the practice of taking very small amounts of psychedelic or psychoactive substances. Psilocybin is the substance most commonly associated with it, though people also microdose LSD, and increasingly report doing the same with everything from mescaline to DMT, amphetamines, and other, in some cases, potentially unsafe research chemicals.

What makes microdosing distinct is not just the amount taken, but the pattern of use. People generally take these substances on a regular schedule over an extended period of time, often following what is known as a protocol. One common protocol involves taking a dose every three days, followed by two to four days off.

The Roots of Microdosing

The current wave of interest in microdosing can be traced to several sources, but one especially notable influence was James Fadiman’s The Psychedelic Explorer’s Guide, which helped popularize both the idea and the terminology. The renewed interest also reflects a broader cultural shift in attitudes toward psychedelics in recent years, along with the easing of some legal restrictions around personal use.

In Colorado, for example, the personal use, cultivation, and sharing of certain natural psychedelic substances, including psilocybin and DMT, are protected under state and some local laws. At the same time, a growing body of research over the last two decades has fueled both public curiosity and scientific interest in the therapeutic potential of psychedelics.

What researchers are trying to understand, and what many of the clients who come to me most want to know, is what has actually been demonstrated through research and how to separate that from anecdote, enthusiasm, and hype. That is not always easy. For now, at least, this remains a complicated and still-emerging area of study, and much more research is needed.

What Does Microdosing Feel Like?

Microdosing can involve a range of substances, often chosen based on a person’s goals, and the experience will vary depending on the substance used. My own experience with microdosing relates almost entirely to psilocybin, so that is what I’ll focus on here.

As the name suggests, microdoses are small. For context, people who microdose dried psilocybin mushrooms typically take between one-tenth of a gram and, on the higher end, about one-third of a gram. By comparison, one gram of dried psilocybin mushrooms is generally considered a conservative recreational dose for most people.

The effects usually begin to emerge anywhere from 30 minutes to an hour after taking a dose, and they tend to be strongest during the two hours that follow. People often describe a sense of “lightness,” as if they feel lighter in their body. Visual experience can also seem a little clearer or more vivid.

Every body is different, and every experience can be different as well. What I’ve noticed is that people often encounter first whatever they are most actively keeping outside of waking awareness. For some, microdosing may bring up anxiety if that is something they have been quietly managing.

Someone carrying unprocessed grief might suddenly find themselves tearing up. Others feel unexpectedly joyful. Part of the usefulness of microdosing may simply be that it allows a person to feel what is present without judgment, and with genuine curiosity and openness.

Common Microdosing Amounts

Microdosing usually involves doses that are sub-hallucinogenic, though not always truly sub-perceptual, as is often assumed. In other words, they don’t typically produce strong or disruptive psychoactive effects.

That said, many people still report noticing effects when they microdose.

According to The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955–2021), the most common amounts vary by substance. In my own experience with dried psilocybin mushrooms, around 0.2 grams is subtle but noticeable, often with a positive lift that doesn’t interfere with daily activities beyond the first hour or so.

These amounts are usually taken two to three days in a row with off days following a schedule or protocol to prevent tolerance buildup and maintain desired effects.

What the Science Says

What the Evidence Suggests

One of the clearest takeaways from the research is that microdosing may produce real effects, but the evidence is uneven. Some findings, such as altered time perception, reduced pain sensitivity, and changes in conscious state, appear in both controlled lab studies and self-report research. These are among the strongest signals that psychedelics in the microdose range can have direct effects.

At the same time, many of the benefits people most often hope for, including better mood, improved creativity, stronger social connection, sharper cognition, and greater emotional ease, appear far more often in self-report studies than they do in laboratory settings.

That does not necessarily mean those benefits are illusory. It may also mean that current lab studies, which tend to focus on short-term effects, are not yet well designed to capture slower, cumulative changes that unfold over time.

Why So Much Still Depends on the Person

A second important takeaway is that microdosing does not seem to affect everyone in the same way. In some studies, the same domains, such as anxiety, energy, focus, and mood, improved for some people and worsened for others.

That suggests context, dose, expectations, environment, and individual biology may all influence whether a microdose feels supportive, neutral, or destabilizing. This aligns with my own experience. How someone responds to a dose can vary widely.

For me, that is one of the most useful ways to understand the current state of the science: not as proof that microdosing is either a miracle or a myth, but as evidence that it is a real, still-emerging practice whose effects appear to be meaningful, variable, and not yet fully understood.

The Role of Placebo and Expectation

Many skeptics, researchers, and a number of reputable studies suggest that the placebo effect plays a significant role in microdosing outcomes.

At the same time, a review of more than 40 microdosing studies offered an important nuance: claims that microdosing is largely placebo-driven may be premature.

The truth likely falls somewhere between two poles. Expectancy can contribute to the overall effect of microdosing, but we still can’t be confident about the magnitude of that effect or its relative importance compared to the pharmacological effects of microdosing itself.

Balancing Benefits with Informed Decision-Making

Microdosing will likely continue to attract attention, in part because the possibilities it hints at are so compelling: greater creativity, more emotional balance, and subtle shifts in how people relate to themselves and their lives.

But the current picture is more complex than either enthusiasts or skeptics sometimes suggest. Anecdotal reports and emerging studies point to real potential, while also underscoring the role of expectation, individual variability, possible risk, and the absence of strong long-term data.

For now, the wisest approach is neither blind enthusiasm nor blanket dismissal, but informed caution, curiosity, and an honest assessment of your own circumstances before deciding whether microdosing is something worth exploring.